Bone scan imaging to identify bone lesions
Part of Bones, joints & muscles clinical trials.
This study uses a special imaging test called SPECT/CT during a bone scan to better understand bone lesions. It may help doctors tell if bone spots are from cancer spread or from wear-and-tear changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are any age and have been referred for a bone scan with SPECT/CT.
- Your doctor suspects the bone lesions might be from cancer that has spread or from degenerative changes.
- You do not have two different types of cancer at the same time.
- You are not pregnant.
- You are not severely ill.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special imaging scan to help doctors tell whether a single bone lesion is benign or malignant. It uses a radioactive tracer that may be more accurate than standard scans, which could improve diagnosis and treatment planning.
This study uses a special whole-body PET/CT scan to help confirm whether a suspicious bone spot or high tumor marker means cancer. It aims to see if this new imaging method can help guide your biopsy and treatment decisions.
This study adds extra measurements during a bone scan to better understand a single unclear spot seen on standard imaging. The goal is to help doctors decide whether a biopsy (sample) or removal is needed, possibly reducing uncertainty.
This study tests a new imaging agent that may help doctors see solid tumor cancers more clearly on a special scan. If you have or may have a solid tumor, this scan could provide more information about your condition.
This study uses a CT scan to estimate how strong a cancer-affected bone area is, helping doctors evaluate fracture risk and bone management. It is aimed at adults with bone lesions from several common cancer types.
This trial uses a special imaging scan (SPECT/CT) with a small amount of radioactive tracer to look at prostate cancer. It aims to see how well the scan matches your prostate cancer tests and may help improve detection and assessment.
Hear when a new Bone Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.